Disease modification in osteoarthritis; pathways to drug approval

Disease modification in osteoarthritis; pathways to drug approval

Summary: Objective: To summarize proceedings of a workshop convened to discuss advances in disease modifying osteoarthritis (OA) drugs and regulatory challenges in bringing these drugs to market. Design: Summary of a one day workshop held in Washington, DC in May 2019. Results: Attendees presented...

Full description

Bibliographic Details
Main Authors: Jeffrey N. Katz, Tuhina Neogi, Leigh F. Callahan, Joel A. Block, Philip G. Conaghan, Lee S. Simon, Virginia Byers Kraus, Marc C. Hochberg
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Osteoarthritis and Cartilage Open
Subjects:
Osteoarthritis
Structure-modifying therapy
Regulatory approval
Online Access:http://www.sciencedirect.com/science/article/pii/S2665913120300480

Internet

http://www.sciencedirect.com/science/article/pii/S2665913120300480

Similar Items